iifl-logo

Parmax Pharma Ltd EGM

Add as a Preferred Source on Google
95.16
(1.99%)
Jul 14, 2026|09:31:00 PM

Parmax Pharma CORPORATE ACTIONS

15/07/2025calendar-icon
15/07/2026calendar-icon
PurposeAnnouncement DateMeeting Date
EGM8 Jun 20262 Jul 2026
The Board has approved the notice of an Extraordinary General Meeting (EGM) of the Company to be held on Thursday, July 2, 2026 at 11.30 am (1ST) through Video Conferencing (VC) / Other Audio Video Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India for obtaining the approval of the shareholders of the Company for the matter as discussed above and such other matters as necessary. The Notice of the Extraordinary General Meeting (EGM) shall be submitted separately in due course. Notice of EGM scheduled to be held on July 02, 2026 (As per BSE Announcement dated on: 09.06.2026) Corrigendum to the EGM Notice dated 8th June 2026 (As Per BSE Announcement Dated on 23.06.2026) Scrutinizer Report and Voting Results Proceeding of 2nd Extra Ordinary General Meeting of the Company (As per BSE Announcement dated on: 02.07.2026)
EGM4 May 202627 May 2026
Notice of Extra-ordinary General Meeting of the Company scheduled to be held on May 27, 2026 Proceedings of EGM held on May 27, 2026 (As Per BSE Announcement Dated on: 31/05/2026). Scrutinizer Report. (As per BSE announcement dated on : 28.05.2026)

Parmax Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.